Try our beta test site

Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison

This study has been completed.
Information provided by:
Norwegian University of Science and Technology Identifier:
First received: July 24, 2006
Last updated: January 25, 2017
Last verified: January 2017
The treatment of ADHD in jail will help the prisoners in their rehabilitation process

Condition Intervention
Attention Deficit Hyperactivity Disorder
Drug: Strattera

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: No masking
Primary Purpose: Treatment
Official Title: Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison

Resource links provided by NLM:

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • The symptoms of Attention Deficit Hyperactive Disorders and the prisoners use of the prisons rehabilitation services before and after treatment will be measured

Estimated Enrollment: 40
Study Start Date: January 2006
Estimated Study Completion Date: December 2006
Detailed Description:
Prisoners with ADHD will be offered treatment with Stratera, and we wanted to study their use of the prisons rehabilitation offers as school, programs and work training before and after treatment with Stratera.

Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

All prisoners that fullfill the diagnostic criterias for ADHD -

Exclusion Criteria:

All other prisoners -

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00356070

St. Olavs Hospital. Departement for forensic psyciatry, Brøset.
Trondheim, Norway, 7040
Sponsors and Collaborators
Norwegian University of Science and Technology
Principal Investigator: Jim Aa Nøttestad, Dr. Philos St. Olavs Hospital, Departement of forensic psychiatry, Brøset
  More Information Identifier: NCT00356070     History of Changes
Other Study ID Numbers: AH 4.2005.147
Study First Received: July 24, 2006
Last Updated: January 25, 2017

Keywords provided by Norwegian University of Science and Technology:
Attention Deficit Hyperactivity Disorder, treatment,

Additional relevant MeSH terms:
Attention Deficit Disorder with Hyperactivity
Pathologic Processes
Attention Deficit and Disruptive Behavior Disorders
Neurodevelopmental Disorders
Mental Disorders
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Atomoxetine Hydrochloride
Adrenergic Uptake Inhibitors
Neurotransmitter Uptake Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Adrenergic Agents
Neurotransmitter Agents
Physiological Effects of Drugs processed this record on March 30, 2017